nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—HDAC6—melanoma	0.463	0.672	CbGaD
Vorinostat—HDAC2—melanoma	0.226	0.328	CbGaD
Vorinostat—Squamous cell carcinoma—Vemurafenib—melanoma	0.00541	0.0866	CcSEcCtD
Vorinostat—HDAC1—manus—melanoma	0.00539	0.084	CbGeAlD
Vorinostat—HDAC1—manual digit—melanoma	0.00527	0.0822	CbGeAlD
Vorinostat—NCOR1—hair follicle—melanoma	0.00402	0.0627	CbGeAlD
Vorinostat—Gastrointestinal toxicity—Carmustine—melanoma	0.00395	0.0633	CcSEcCtD
Vorinostat—Azelaic Acid—TYR—melanoma	0.00372	1	CrCbGaD
Vorinostat—HDAC3—hair follicle—melanoma	0.00352	0.0549	CbGeAlD
Vorinostat—HDAC1—hair follicle—melanoma	0.00323	0.0503	CbGeAlD
Vorinostat—NCOR1—neck—melanoma	0.0027	0.042	CbGeAlD
Vorinostat—HDAC1—neck—melanoma	0.00216	0.0337	CbGeAlD
Vorinostat—HDAC11—eye—melanoma	0.00207	0.0322	CbGeAlD
Vorinostat—NCOR1—skin of body—melanoma	0.00174	0.0272	CbGeAlD
Vorinostat—HDAC3—retina—melanoma	0.00174	0.0272	CbGeAlD
Vorinostat—HDAC11—mammalian vulva—melanoma	0.00164	0.0256	CbGeAlD
Vorinostat—HDAC2—hair follicle—melanoma	0.00162	0.0253	CbGeAlD
Vorinostat—HDAC1—eye—melanoma	0.00161	0.0251	CbGeAlD
Vorinostat—HDAC1—retina—melanoma	0.0016	0.0249	CbGeAlD
Vorinostat—Myelosuppression—Bleomycin—melanoma	0.00159	0.0254	CcSEcCtD
Vorinostat—HDAC9—eye—melanoma	0.00158	0.0247	CbGeAlD
Vorinostat—HDAC3—skin of body—melanoma	0.00153	0.0238	CbGeAlD
Vorinostat—HDAC6—head—melanoma	0.00152	0.0237	CbGeAlD
Vorinostat—Myelosuppression—Dactinomycin—melanoma	0.00148	0.0237	CcSEcCtD
Vorinostat—Neoplasm malignant—Vemurafenib—melanoma	0.00144	0.023	CcSEcCtD
Vorinostat—HDAC1—skin of body—melanoma	0.0014	0.0218	CbGeAlD
Vorinostat—HDAC3—mammalian vulva—melanoma	0.00139	0.0217	CbGeAlD
Vorinostat—Myelosuppression—Carmustine—melanoma	0.00138	0.0222	CcSEcCtD
Vorinostat—Myelosuppression—Temozolomide—melanoma	0.00134	0.0214	CcSEcCtD
Vorinostat—HDAC4—head—melanoma	0.00131	0.0204	CbGeAlD
Vorinostat—HDAC1—mammalian vulva—melanoma	0.00128	0.0199	CbGeAlD
Vorinostat—HDAC11—head—melanoma	0.00117	0.0183	CbGeAlD
Vorinostat—NCOR1—head—melanoma	0.00114	0.0178	CbGeAlD
Vorinostat—HDAC2—neck—melanoma	0.00109	0.017	CbGeAlD
Vorinostat—HDAC6—lymph node—melanoma	0.00106	0.0166	CbGeAlD
Vorinostat—Deep vein thrombosis—Temozolomide—melanoma	0.00103	0.0165	CcSEcCtD
Vorinostat—HDAC3—head—melanoma	0.000998	0.0156	CbGeAlD
Vorinostat—Embolism—Temozolomide—melanoma	0.000977	0.0156	CcSEcCtD
Vorinostat—HDAC8—lymph node—melanoma	0.000942	0.0147	CbGeAlD
Vorinostat—HDAC4—lymph node—melanoma	0.000915	0.0143	CbGeAlD
Vorinostat—HDAC1—head—melanoma	0.000914	0.0142	CbGeAlD
Vorinostat—HDAC9—head—melanoma	0.000899	0.014	CbGeAlD
Vorinostat—Myelosuppression—Docetaxel—melanoma	0.00089	0.0142	CcSEcCtD
Vorinostat—HDAC11—lymph node—melanoma	0.000822	0.0128	CbGeAlD
Vorinostat—Abscess—Carmustine—melanoma	0.00082	0.0131	CcSEcCtD
Vorinostat—HDAC2—eye—melanoma	0.000809	0.0126	CbGeAlD
Vorinostat—HDAC2—retina—melanoma	0.000802	0.0125	CbGeAlD
Vorinostat—NCOR1—lymph node—melanoma	0.000797	0.0124	CbGeAlD
Vorinostat—HDAC2—skin of body—melanoma	0.000704	0.011	CbGeAlD
Vorinostat—HDAC3—lymph node—melanoma	0.000699	0.0109	CbGeAlD
Vorinostat—Weight decreased—Vemurafenib—melanoma	0.000697	0.0112	CcSEcCtD
Vorinostat—Deep vein thrombosis—Docetaxel—melanoma	0.000686	0.011	CcSEcCtD
Vorinostat—Embolism—Docetaxel—melanoma	0.00065	0.0104	CcSEcCtD
Vorinostat—Pulmonary embolism—Carmustine—melanoma	0.000649	0.0104	CcSEcCtD
Vorinostat—HDAC1—lymph node—melanoma	0.00064	0.00998	CbGeAlD
Vorinostat—HDAC9—lymph node—melanoma	0.000629	0.00981	CbGeAlD
Vorinostat—Pulmonary embolism—Temozolomide—melanoma	0.000627	0.01	CcSEcCtD
Vorinostat—Oedema peripheral—Vemurafenib—melanoma	0.000607	0.00972	CcSEcCtD
Vorinostat—Sepsis—Dactinomycin—melanoma	0.000602	0.00964	CcSEcCtD
Vorinostat—Sepsis—Carmustine—melanoma	0.000563	0.00902	CcSEcCtD
Vorinostat—Chills—Vemurafenib—melanoma	0.000553	0.00886	CcSEcCtD
Vorinostat—Alopecia—Vemurafenib—melanoma	0.000545	0.00872	CcSEcCtD
Vorinostat—Dysgeusia—Vemurafenib—melanoma	0.000525	0.00841	CcSEcCtD
Vorinostat—Lethargy—Dactinomycin—melanoma	0.000514	0.00823	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Temozolomide—melanoma	0.000483	0.00773	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Carmustine—melanoma	0.000471	0.00755	CcSEcCtD
Vorinostat—Cough—Vemurafenib—melanoma	0.000468	0.0075	CcSEcCtD
Vorinostat—HDAC2—head—melanoma	0.00046	0.00717	CbGeAlD
Vorinostat—Pancytopenia—Bleomycin—melanoma	0.000443	0.0071	CcSEcCtD
Vorinostat—Infection—Vemurafenib—melanoma	0.000435	0.00697	CcSEcCtD
Vorinostat—Hypokalaemia—Carmustine—melanoma	0.000429	0.00687	CcSEcCtD
Vorinostat—Dehydration—Temozolomide—melanoma	0.000423	0.00678	CcSEcCtD
Vorinostat—Weight decreased—Bleomycin—melanoma	0.000422	0.00676	CcSEcCtD
Vorinostat—Pulmonary embolism—Docetaxel—melanoma	0.000417	0.00668	CcSEcCtD
Vorinostat—Hypokalaemia—Temozolomide—melanoma	0.000414	0.00664	CcSEcCtD
Vorinostat—Pancytopenia—Dactinomycin—melanoma	0.000413	0.00662	CcSEcCtD
Vorinostat—Acute coronary syndrome—Bleomycin—melanoma	0.00041	0.00657	CcSEcCtD
Vorinostat—Myocardial infarction—Bleomycin—melanoma	0.000408	0.00653	CcSEcCtD
Vorinostat—Neutropenia—Dactinomycin—melanoma	0.000407	0.00652	CcSEcCtD
Vorinostat—Pancytopenia—Carmustine—melanoma	0.000387	0.00619	CcSEcCtD
Vorinostat—Neutropenia—Carmustine—melanoma	0.000381	0.0061	CcSEcCtD
Vorinostat—Decreased appetite—Vemurafenib—melanoma	0.000381	0.0061	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Vemurafenib—melanoma	0.000378	0.00605	CcSEcCtD
Vorinostat—Fatigue—Vemurafenib—melanoma	0.000378	0.00605	CcSEcCtD
Vorinostat—Constipation—Vemurafenib—melanoma	0.000374	0.006	CcSEcCtD
Vorinostat—Pancytopenia—Temozolomide—melanoma	0.000374	0.00599	CcSEcCtD
Vorinostat—Neutropenia—Temozolomide—melanoma	0.000368	0.00589	CcSEcCtD
Vorinostat—Hyperglycaemia—Carmustine—melanoma	0.000367	0.00588	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Temozolomide—melanoma	0.000366	0.00586	CcSEcCtD
Vorinostat—Sepsis—Docetaxel—melanoma	0.000362	0.0058	CcSEcCtD
Vorinostat—Weight decreased—Temozolomide—melanoma	0.000356	0.0057	CcSEcCtD
Vorinostat—Hyperglycaemia—Temozolomide—melanoma	0.000355	0.00569	CcSEcCtD
Vorinostat—Body temperature increased—Vemurafenib—melanoma	0.000346	0.00554	CcSEcCtD
Vorinostat—Chills—Bleomycin—melanoma	0.000335	0.00537	CcSEcCtD
Vorinostat—Alopecia—Bleomycin—melanoma	0.00033	0.00528	CcSEcCtD
Vorinostat—HDAC2—lymph node—melanoma	0.000322	0.00502	CbGeAlD
Vorinostat—Oedema peripheral—Carmustine—melanoma	0.000321	0.00514	CcSEcCtD
Vorinostat—Asthenia—Vemurafenib—melanoma	0.000314	0.00503	CcSEcCtD
Vorinostat—Chills—Dactinomycin—melanoma	0.000312	0.005	CcSEcCtD
Vorinostat—Oedema peripheral—Temozolomide—melanoma	0.00031	0.00497	CcSEcCtD
Vorinostat—Pruritus—Vemurafenib—melanoma	0.00031	0.00496	CcSEcCtD
Vorinostat—Lethargy—Docetaxel—melanoma	0.000309	0.00495	CcSEcCtD
Vorinostat—Alopecia—Dactinomycin—melanoma	0.000308	0.00493	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000303	0.00485	CcSEcCtD
Vorinostat—Anaemia—Bleomycin—melanoma	0.0003	0.00481	CcSEcCtD
Vorinostat—Diarrhoea—Vemurafenib—melanoma	0.0003	0.0048	CcSEcCtD
Vorinostat—Leukopenia—Bleomycin—melanoma	0.000291	0.00466	CcSEcCtD
Vorinostat—Dizziness—Vemurafenib—melanoma	0.00029	0.00464	CcSEcCtD
Vorinostat—Alopecia—Carmustine—melanoma	0.000288	0.00461	CcSEcCtD
Vorinostat—Cough—Bleomycin—melanoma	0.000284	0.00454	CcSEcCtD
Vorinostat—Chills—Temozolomide—melanoma	0.000283	0.00453	CcSEcCtD
Vorinostat—Dehydration—Docetaxel—melanoma	0.000282	0.00451	CcSEcCtD
Vorinostat—Anaemia—Dactinomycin—melanoma	0.00028	0.00449	CcSEcCtD
Vorinostat—Vomiting—Vemurafenib—melanoma	0.000278	0.00446	CcSEcCtD
Vorinostat—Alopecia—Temozolomide—melanoma	0.000278	0.00446	CcSEcCtD
Vorinostat—Chest pain—Bleomycin—melanoma	0.000277	0.00443	CcSEcCtD
Vorinostat—Headache—Vemurafenib—melanoma	0.000274	0.00439	CcSEcCtD
Vorinostat—Leukopenia—Dactinomycin—melanoma	0.000271	0.00435	CcSEcCtD
Vorinostat—Dysgeusia—Temozolomide—melanoma	0.000269	0.0043	CcSEcCtD
Vorinostat—Infection—Bleomycin—melanoma	0.000264	0.00422	CcSEcCtD
Vorinostat—Anaemia—Carmustine—melanoma	0.000262	0.0042	CcSEcCtD
Vorinostat—Nausea—Vemurafenib—melanoma	0.00026	0.00417	CcSEcCtD
Vorinostat—Thrombocytopenia—Bleomycin—melanoma	0.00026	0.00416	CcSEcCtD
Vorinostat—Leukopenia—Carmustine—melanoma	0.000254	0.00407	CcSEcCtD
Vorinostat—Anaemia—Temozolomide—melanoma	0.000253	0.00406	CcSEcCtD
Vorinostat—Anorexia—Bleomycin—melanoma	0.000253	0.00405	CcSEcCtD
Vorinostat—Angioedema—Temozolomide—melanoma	0.000251	0.00401	CcSEcCtD
Vorinostat—Pancytopenia—Docetaxel—melanoma	0.000249	0.00398	CcSEcCtD
Vorinostat—Infection—Dactinomycin—melanoma	0.000246	0.00394	CcSEcCtD
Vorinostat—Leukopenia—Temozolomide—melanoma	0.000245	0.00393	CcSEcCtD
Vorinostat—Neutropenia—Docetaxel—melanoma	0.000245	0.00392	CcSEcCtD
Vorinostat—Thrombocytopenia—Dactinomycin—melanoma	0.000242	0.00388	CcSEcCtD
Vorinostat—Chest pain—Carmustine—melanoma	0.000242	0.00387	CcSEcCtD
Vorinostat—Cough—Temozolomide—melanoma	0.000239	0.00383	CcSEcCtD
Vorinostat—Weight decreased—Docetaxel—melanoma	0.000237	0.00379	CcSEcCtD
Vorinostat—Anorexia—Dactinomycin—melanoma	0.000236	0.00378	CcSEcCtD
Vorinostat—Decreased appetite—Bleomycin—melanoma	0.000231	0.00369	CcSEcCtD
Vorinostat—Infection—Carmustine—melanoma	0.00023	0.00368	CcSEcCtD
Vorinostat—Acute coronary syndrome—Docetaxel—melanoma	0.00023	0.00368	CcSEcCtD
Vorinostat—Myocardial infarction—Docetaxel—melanoma	0.000229	0.00366	CcSEcCtD
Vorinostat—Dry mouth—Temozolomide—melanoma	0.000228	0.00366	CcSEcCtD
Vorinostat—Thrombocytopenia—Carmustine—melanoma	0.000227	0.00363	CcSEcCtD
Vorinostat—Infection—Temozolomide—melanoma	0.000222	0.00356	CcSEcCtD
Vorinostat—Anorexia—Carmustine—melanoma	0.000221	0.00354	CcSEcCtD
Vorinostat—Thrombocytopenia—Temozolomide—melanoma	0.000219	0.00351	CcSEcCtD
Vorinostat—Decreased appetite—Dactinomycin—melanoma	0.000215	0.00344	CcSEcCtD
Vorinostat—Fatigue—Dactinomycin—melanoma	0.000213	0.00342	CcSEcCtD
Vorinostat—Anorexia—Temozolomide—melanoma	0.000213	0.00342	CcSEcCtD
Vorinostat—Body temperature increased—Bleomycin—melanoma	0.00021	0.00336	CcSEcCtD
Vorinostat—Oedema peripheral—Docetaxel—melanoma	0.000206	0.0033	CcSEcCtD
Vorinostat—Decreased appetite—Carmustine—melanoma	0.000201	0.00322	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Carmustine—melanoma	0.0002	0.0032	CcSEcCtD
Vorinostat—Constipation—Carmustine—melanoma	0.000198	0.00317	CcSEcCtD
Vorinostat—Body temperature increased—Dactinomycin—melanoma	0.000196	0.00313	CcSEcCtD
Vorinostat—Decreased appetite—Temozolomide—melanoma	0.000195	0.00312	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Temozolomide—melanoma	0.000193	0.00309	CcSEcCtD
Vorinostat—Fatigue—Temozolomide—melanoma	0.000193	0.00309	CcSEcCtD
Vorinostat—Constipation—Temozolomide—melanoma	0.000191	0.00306	CcSEcCtD
Vorinostat—Asthenia—Bleomycin—melanoma	0.00019	0.00305	CcSEcCtD
Vorinostat—Chills—Docetaxel—melanoma	0.000188	0.00301	CcSEcCtD
Vorinostat—Pruritus—Bleomycin—melanoma	0.000188	0.00301	CcSEcCtD
Vorinostat—Alopecia—Docetaxel—melanoma	0.000185	0.00296	CcSEcCtD
Vorinostat—Body temperature increased—Carmustine—melanoma	0.000183	0.00293	CcSEcCtD
Vorinostat—Dysgeusia—Docetaxel—melanoma	0.000179	0.00286	CcSEcCtD
Vorinostat—Asthenia—Dactinomycin—melanoma	0.000178	0.00284	CcSEcCtD
Vorinostat—Body temperature increased—Temozolomide—melanoma	0.000177	0.00283	CcSEcCtD
Vorinostat—Muscle spasms—Docetaxel—melanoma	0.000175	0.00281	CcSEcCtD
Vorinostat—Diarrhoea—Dactinomycin—melanoma	0.000169	0.00271	CcSEcCtD
Vorinostat—Vomiting—Bleomycin—melanoma	0.000169	0.0027	CcSEcCtD
Vorinostat—Anaemia—Docetaxel—melanoma	0.000169	0.0027	CcSEcCtD
Vorinostat—Asthenia—Carmustine—melanoma	0.000166	0.00266	CcSEcCtD
Vorinostat—Syncope—Docetaxel—melanoma	0.000164	0.00262	CcSEcCtD
Vorinostat—Leukopenia—Docetaxel—melanoma	0.000163	0.00261	CcSEcCtD
Vorinostat—Asthenia—Temozolomide—melanoma	0.000161	0.00257	CcSEcCtD
Vorinostat—Loss of consciousness—Docetaxel—melanoma	0.00016	0.00257	CcSEcCtD
Vorinostat—Cough—Docetaxel—melanoma	0.000159	0.00255	CcSEcCtD
Vorinostat—Diarrhoea—Carmustine—melanoma	0.000158	0.00254	CcSEcCtD
Vorinostat—Pruritus—Temozolomide—melanoma	0.000158	0.00254	CcSEcCtD
Vorinostat—Nausea—Bleomycin—melanoma	0.000158	0.00252	CcSEcCtD
Vorinostat—Vomiting—Dactinomycin—melanoma	0.000157	0.00252	CcSEcCtD
Vorinostat—Chest pain—Docetaxel—melanoma	0.000155	0.00249	CcSEcCtD
Vorinostat—Dizziness—Carmustine—melanoma	0.000153	0.00245	CcSEcCtD
Vorinostat—Diarrhoea—Temozolomide—melanoma	0.000153	0.00245	CcSEcCtD
Vorinostat—Dry mouth—Docetaxel—melanoma	0.000152	0.00243	CcSEcCtD
Vorinostat—Dizziness—Temozolomide—melanoma	0.000148	0.00237	CcSEcCtD
Vorinostat—Infection—Docetaxel—melanoma	0.000148	0.00237	CcSEcCtD
Vorinostat—Vomiting—Carmustine—melanoma	0.000147	0.00236	CcSEcCtD
Vorinostat—Nausea—Dactinomycin—melanoma	0.000147	0.00235	CcSEcCtD
Vorinostat—Shock—Docetaxel—melanoma	0.000146	0.00234	CcSEcCtD
Vorinostat—Thrombocytopenia—Docetaxel—melanoma	0.000146	0.00233	CcSEcCtD
Vorinostat—Headache—Carmustine—melanoma	0.000145	0.00232	CcSEcCtD
Vorinostat—Vomiting—Temozolomide—melanoma	0.000142	0.00228	CcSEcCtD
Vorinostat—Anorexia—Docetaxel—melanoma	0.000142	0.00227	CcSEcCtD
Vorinostat—Headache—Temozolomide—melanoma	0.00014	0.00225	CcSEcCtD
Vorinostat—Nausea—Carmustine—melanoma	0.000138	0.0022	CcSEcCtD
Vorinostat—Nausea—Temozolomide—melanoma	0.000133	0.00213	CcSEcCtD
Vorinostat—Decreased appetite—Docetaxel—melanoma	0.000129	0.00207	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Docetaxel—melanoma	0.000128	0.00206	CcSEcCtD
Vorinostat—Fatigue—Docetaxel—melanoma	0.000128	0.00205	CcSEcCtD
Vorinostat—Constipation—Docetaxel—melanoma	0.000127	0.00204	CcSEcCtD
Vorinostat—Body temperature increased—Docetaxel—melanoma	0.000118	0.00188	CcSEcCtD
Vorinostat—Asthenia—Docetaxel—melanoma	0.000107	0.00171	CcSEcCtD
Vorinostat—Pruritus—Docetaxel—melanoma	0.000105	0.00169	CcSEcCtD
Vorinostat—Diarrhoea—Docetaxel—melanoma	0.000102	0.00163	CcSEcCtD
Vorinostat—Dizziness—Docetaxel—melanoma	9.84e-05	0.00158	CcSEcCtD
Vorinostat—Vomiting—Docetaxel—melanoma	9.46e-05	0.00152	CcSEcCtD
Vorinostat—Headache—Docetaxel—melanoma	9.32e-05	0.00149	CcSEcCtD
Vorinostat—Nausea—Docetaxel—melanoma	8.84e-05	0.00142	CcSEcCtD
Vorinostat—HDAC2—Gene Expression—PPARG—melanoma	4.06e-06	2.25e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—ERBB2—melanoma	4.04e-06	2.24e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—VEGFA—melanoma	4.03e-06	2.23e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NOS2—melanoma	4.03e-06	2.23e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CDKN1A—melanoma	4.02e-06	2.23e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MYC—melanoma	4.02e-06	2.22e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PTEN—melanoma	4.01e-06	2.22e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—MAPK1—melanoma	4e-06	2.21e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—EGFR—melanoma	4e-06	2.21e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NOTCH1—melanoma	4e-06	2.21e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—STAT3—melanoma	3.99e-06	2.21e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CASP3—melanoma	3.99e-06	2.21e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PIK3CB—melanoma	3.99e-06	2.21e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—BRAF—melanoma	3.99e-06	2.21e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—IL6—melanoma	3.99e-06	2.21e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IL2—melanoma	3.99e-06	2.21e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—NRAS—melanoma	3.98e-06	2.2e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—IL6—melanoma	3.98e-06	2.2e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—AKT1—melanoma	3.98e-06	2.2e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MAPK1—melanoma	3.93e-06	2.18e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—EGFR—melanoma	3.93e-06	2.18e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ERBB4—melanoma	3.92e-06	2.17e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CD80—melanoma	3.91e-06	2.16e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—APC—melanoma	3.91e-06	2.16e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—KIT—melanoma	3.91e-06	2.16e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—HRAS—melanoma	3.89e-06	2.15e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CCND1—melanoma	3.89e-06	2.15e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IGF1—melanoma	3.89e-06	2.15e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CDKN2B—melanoma	3.88e-06	2.15e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—EGF—melanoma	3.86e-06	2.14e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CTNNB1—melanoma	3.85e-06	2.13e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CXCL8—melanoma	3.83e-06	2.12e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MAPK3—melanoma	3.82e-06	2.11e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—KRAS—melanoma	3.78e-06	2.09e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—PIK3CA—melanoma	3.78e-06	2.09e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—PIK3CA—melanoma	3.78e-06	2.09e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MMP9—melanoma	3.77e-06	2.09e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—VEGFA—melanoma	3.77e-06	2.09e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—PIK3CA—melanoma	3.77e-06	2.08e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CDKN1A—melanoma	3.76e-06	2.08e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MAP2K1—melanoma	3.76e-06	2.08e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CD86—melanoma	3.76e-06	2.08e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PTEN—melanoma	3.75e-06	2.08e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CDKN1B—melanoma	3.75e-06	2.07e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—STAT3—melanoma	3.74e-06	2.07e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—NFKB1—melanoma	3.73e-06	2.07e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3CD—melanoma	3.73e-06	2.06e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EDN1—melanoma	3.73e-06	2.06e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—NRAS—melanoma	3.73e-06	2.06e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—IL6—melanoma	3.73e-06	2.06e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—KRAS—melanoma	3.72e-06	2.06e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MYC—melanoma	3.71e-06	2.05e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—MAPK3—melanoma	3.69e-06	2.04e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—AKT1—melanoma	3.68e-06	2.04e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—AKT1—melanoma	3.68e-06	2.03e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—BRAF—melanoma	3.67e-06	2.03e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CASP3—melanoma	3.67e-06	2.03e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IL2—melanoma	3.66e-06	2.03e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TP53—melanoma	3.65e-06	2.02e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—TP53—melanoma	3.65e-06	2.02e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FGF1—melanoma	3.64e-06	2.01e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CSF2—melanoma	3.64e-06	2.01e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MAPK1—melanoma	3.63e-06	2.01e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—EGFR—melanoma	3.63e-06	2.01e-05	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—AKT1—melanoma	3.59e-06	1.99e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—MYC—melanoma	3.59e-06	1.99e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—STAT3—melanoma	3.59e-06	1.99e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—NRAS—melanoma	3.58e-06	1.98e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—FGF2—melanoma	3.57e-06	1.98e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CCND1—melanoma	3.57e-06	1.98e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MAPK3—melanoma	3.57e-06	1.97e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—E2F1—melanoma	3.57e-06	1.97e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CTNNB1—melanoma	3.54e-06	1.96e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PDGFRA—melanoma	3.53e-06	1.95e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—HRAS—melanoma	3.5e-06	1.93e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ITGB3—melanoma	3.49e-06	1.93e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PRKCA—melanoma	3.49e-06	1.93e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—HRAS—melanoma	3.49e-06	1.93e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—HRAS—melanoma	3.49e-06	1.93e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—PIK3CA—melanoma	3.47e-06	1.92e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MYC—melanoma	3.47e-06	1.92e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MMP9—melanoma	3.47e-06	1.92e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MAP2K1—melanoma	3.46e-06	1.91e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CDKN1A—melanoma	3.46e-06	1.91e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PTEN—melanoma	3.45e-06	1.91e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—AKT1—melanoma	3.44e-06	1.9e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PIK3CD—melanoma	3.43e-06	1.9e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—NFKB1—melanoma	3.43e-06	1.9e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MAPK3—melanoma	3.43e-06	1.9e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—KRAS—melanoma	3.43e-06	1.9e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SPP1—melanoma	3.43e-06	1.89e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MAP2K2—melanoma	3.41e-06	1.89e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—PIK3CA—melanoma	3.41e-06	1.89e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MAPK1—melanoma	3.4e-06	1.88e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—EGFR—melanoma	3.4e-06	1.88e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—VEGFA—melanoma	3.39e-06	1.87e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—STAT3—melanoma	3.36e-06	1.86e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—NRAS—melanoma	3.35e-06	1.85e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—IL6—melanoma	3.35e-06	1.85e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MDM2—melanoma	3.34e-06	1.85e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—IL6—melanoma	3.34e-06	1.85e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MYC—melanoma	3.34e-06	1.84e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TP53—melanoma	3.3e-06	1.83e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—ERBB2—melanoma	3.3e-06	1.82e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—FGF2—melanoma	3.29e-06	1.82e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MAPK1—melanoma	3.26e-06	1.8e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—EGFR—melanoma	3.26e-06	1.8e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3CB—melanoma	3.25e-06	1.8e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TERT—melanoma	3.25e-06	1.8e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—RAC1—melanoma	3.24e-06	1.79e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—HRAS—melanoma	3.21e-06	1.78e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—KRAS—melanoma	3.21e-06	1.77e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MAPK3—melanoma	3.21e-06	1.77e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PIK3CA—melanoma	3.17e-06	1.75e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—HRAS—melanoma	3.16e-06	1.75e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PIK3CA—melanoma	3.15e-06	1.74e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CXCL8—melanoma	3.13e-06	1.73e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MYC—melanoma	3.12e-06	1.72e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—VEGFA—melanoma	3.11e-06	1.72e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HIF1A—melanoma	3.11e-06	1.72e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—AKT1—melanoma	3.09e-06	1.71e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—AKT1—melanoma	3.08e-06	1.71e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—STAT3—melanoma	3.08e-06	1.71e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—KRAS—melanoma	3.08e-06	1.7e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—AKT1—melanoma	3.08e-06	1.7e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MDM2—melanoma	3.08e-06	1.7e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—NRAS—melanoma	3.08e-06	1.7e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—IL6—melanoma	3.08e-06	1.7e-05	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—AKT1—melanoma	3.06e-06	1.69e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CDKN1B—melanoma	3.05e-06	1.69e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MAPK1—melanoma	3.05e-06	1.69e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—EGFR—melanoma	3.05e-06	1.69e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TP53—melanoma	3.05e-06	1.69e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—ERBB2—melanoma	3.03e-06	1.68e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—IL6—melanoma	3.02e-06	1.67e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PIK3CB—melanoma	2.99e-06	1.66e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CASP3—melanoma	2.99e-06	1.65e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CD4—melanoma	2.99e-06	1.65e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IL2—melanoma	2.99e-06	1.65e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KDR—melanoma	2.97e-06	1.64e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PTGS2—melanoma	2.97e-06	1.64e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PIK3CA—melanoma	2.95e-06	1.63e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MAPK3—melanoma	2.95e-06	1.63e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—HRAS—melanoma	2.92e-06	1.61e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CCND1—melanoma	2.91e-06	1.61e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PIK3CA—melanoma	2.91e-06	1.61e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CTNNB1—melanoma	2.88e-06	1.6e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—KRAS—melanoma	2.88e-06	1.59e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MYC—melanoma	2.87e-06	1.58e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FN1—melanoma	2.86e-06	1.58e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TP53—melanoma	2.85e-06	1.58e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—AKT1—melanoma	2.84e-06	1.57e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PIK3CA—melanoma	2.83e-06	1.57e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MMP9—melanoma	2.83e-06	1.56e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CDKN1A—melanoma	2.82e-06	1.56e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PTEN—melanoma	2.81e-06	1.55e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CDKN1B—melanoma	2.81e-06	1.55e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MAPK1—melanoma	2.8e-06	1.55e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—EGFR—melanoma	2.8e-06	1.55e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NOTCH1—melanoma	2.8e-06	1.55e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NFKB1—melanoma	2.8e-06	1.55e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—IL6—melanoma	2.79e-06	1.54e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—AKT1—melanoma	2.79e-06	1.54e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CD80—melanoma	2.74e-06	1.52e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CG—melanoma	2.74e-06	1.51e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—APC—melanoma	2.74e-06	1.51e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KIT—melanoma	2.74e-06	1.51e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—HRAS—melanoma	2.73e-06	1.51e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EGF—melanoma	2.7e-06	1.5e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CTNNB1—melanoma	2.65e-06	1.47e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—KRAS—melanoma	2.65e-06	1.46e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PIK3CA—melanoma	2.65e-06	1.46e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—HRAS—melanoma	2.62e-06	1.45e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—IL6—melanoma	2.61e-06	1.44e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CDKN1A—melanoma	2.59e-06	1.43e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PTEN—melanoma	2.59e-06	1.43e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—AKT1—melanoma	2.59e-06	1.43e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—AKT1—melanoma	2.57e-06	1.42e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—BRAF—melanoma	2.57e-06	1.42e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TP53—melanoma	2.56e-06	1.42e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—VEGFA—melanoma	2.54e-06	1.4e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—STAT3—melanoma	2.51e-06	1.39e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NRAS—melanoma	2.51e-06	1.39e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—IL6—melanoma	2.51e-06	1.39e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IGF1—melanoma	2.5e-06	1.39e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—AKT1—melanoma	2.49e-06	1.38e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—HRAS—melanoma	2.45e-06	1.35e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PIK3CA—melanoma	2.43e-06	1.35e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MAP2K1—melanoma	2.42e-06	1.34e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—AKT1—melanoma	2.41e-06	1.33e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CD—melanoma	2.41e-06	1.33e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MAPK3—melanoma	2.4e-06	1.33e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—MAPK3—melanoma	2.38e-06	1.32e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—AKT1—melanoma	2.38e-06	1.31e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TP53—melanoma	2.35e-06	1.3e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IL6—melanoma	2.34e-06	1.3e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MYC—melanoma	2.34e-06	1.29e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—MYC—melanoma	2.32e-06	1.28e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—STAT3—melanoma	2.31e-06	1.28e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—AKT1—melanoma	2.31e-06	1.28e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NRAS—melanoma	2.31e-06	1.28e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FGF2—melanoma	2.3e-06	1.27e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MAPK1—melanoma	2.29e-06	1.26e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—EGFR—melanoma	2.28e-06	1.26e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—HRAS—melanoma	2.25e-06	1.24e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MAPK3—melanoma	2.21e-06	1.22e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—AKT1—melanoma	2.16e-06	1.2e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KRAS—melanoma	2.16e-06	1.19e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MDM2—melanoma	2.15e-06	1.19e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IL6—melanoma	2.15e-06	1.19e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MYC—melanoma	2.15e-06	1.19e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ERBB2—melanoma	2.12e-06	1.17e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MAPK1—melanoma	2.1e-06	1.16e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—EGFR—melanoma	2.1e-06	1.16e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CB—melanoma	2.1e-06	1.16e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CXCL8—melanoma	2.01e-06	1.11e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—AKT1—melanoma	1.99e-06	1.1e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—KRAS—melanoma	1.99e-06	1.1e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3CA—melanoma	1.98e-06	1.1e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CDKN1B—melanoma	1.97e-06	1.09e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CASP3—melanoma	1.93e-06	1.07e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IL2—melanoma	1.93e-06	1.06e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TP53—melanoma	1.92e-06	1.06e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CCND1—melanoma	1.88e-06	1.04e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CTNNB1—melanoma	1.86e-06	1.03e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—HRAS—melanoma	1.83e-06	1.01e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PIK3CA—melanoma	1.82e-06	1.01e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MMP9—melanoma	1.82e-06	1.01e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CDKN1A—melanoma	1.82e-06	1e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PTEN—melanoma	1.81e-06	1e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NFKB1—melanoma	1.8e-06	9.97e-06	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IL6—melanoma	1.76e-06	9.71e-06	CbGpPWpGaD
Vorinostat—HDAC2—Disease—HRAS—melanoma	1.69e-06	9.34e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—VEGFA—melanoma	1.64e-06	9.05e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—STAT3—melanoma	1.62e-06	8.96e-06	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—AKT1—melanoma	1.62e-06	8.96e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NRAS—melanoma	1.62e-06	8.94e-06	CbGpPWpGaD
Vorinostat—HDAC2—Disease—IL6—melanoma	1.62e-06	8.94e-06	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—AKT1—melanoma	1.61e-06	8.88e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MAPK3—melanoma	1.55e-06	8.56e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MYC—melanoma	1.51e-06	8.33e-06	CbGpPWpGaD
Vorinostat—HDAC2—Disease—AKT1—melanoma	1.49e-06	8.24e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MAPK1—melanoma	1.47e-06	8.14e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EGFR—melanoma	1.47e-06	8.14e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KRAS—melanoma	1.39e-06	7.69e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CA—melanoma	1.28e-06	7.07e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TP53—melanoma	1.24e-06	6.84e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HRAS—melanoma	1.18e-06	6.54e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IL6—melanoma	1.13e-06	6.26e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—AKT1—melanoma	1.04e-06	5.77e-06	CbGpPWpGaD
